Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.66 - $13.96 $4,413 - $13,220
-947 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$11.89 - $24.68 $3,911 - $8,119
329 Added 53.24%
947 $12,000
Q4 2021

Feb 11, 2022

BUY
$24.14 - $35.18 $4,055 - $5,910
168 Added 37.33%
618 $15,000
Q3 2021

Feb 11, 2022

SELL
$27.38 - $42.21 $5,914 - $9,117
-216 Reduced 32.43%
450 $15,000
Q2 2021

Feb 11, 2022

BUY
$26.34 - $46.62 $8,297 - $14,685
315 Added 89.74%
666 $19,000
Q1 2021

Feb 08, 2022

BUY
$45.96 - $68.02 $16,131 - $23,875
351 New
351 $18,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.